Modern AI implementation requires a sophisticated infrastructure to handle prompt management, retrieval pipelines, model routing, and safety monitoring across the entire value chain. Despite a global investment of 250 billion dollars in artificial intelligence last year, the pharmaceutical sector
Researchers can now screen thousands of potential drug compounds more quickly by observing how human cells interact with experimental treatments in a controlled laboratory setting. This breakthrough, led by experts from the Florey Institute and Monash University, marks a turning point in the study
Relying solely on analytics is insufficient when insights remain trapped within departmental silos rather than being activated at the point of direct patient care. For years, health systems have funneled capital into predictive modeling, yet the promise of value-based care often feels like a
Healthcare providers and insurance companies are currently locked in an administrative arms race where AI is used both to generate bills and to aggressively deny them. This technological tug-of-war has sparked a heated national debate over whether artificial intelligence is genuinely improving
James Maitland has spent his career at the cutting edge of medical technology, specializing in how robotics and the Internet of Things can bridge the gap between high-tech medical centers and remote clinics. As an advocate for global health equity, he has closely monitored how software intelligence
The FDA’s authorization of the HIF-2α inhibitor belzutifan for kidney cancer treatment highlights a broader industry movement toward targeting complex biological pathways through synergistic combination therapies. This regulatory milestone serves as a definitive marker for the current era of drug
